Emerald Mutual Fund Advisers Trust’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Emerald Mutual Fund Advisers Trust's GH Position: Q2 2026 in Review
Emerald Mutual Fund Advisers Trust reduced its Guardant Health (GH) stake by 48% in Q2 2026, selling an estimated $27M and leaving 271,380 shares worth $40.7M. The position accounts for 1.43% of the portfolio, ranked #14.
Emerald Mutual Fund Advisers Trust first reported a position in GH in Q1 2025 and has held it in 6 quarters since. The position peaked at $53.5M in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Emerald Mutual Fund Advisers Trust held 271,380 shares of Guardant Health worth $40.7M as of Q2 2026.
- Emerald Mutual Fund Advisers Trust sold 248,165 Guardant Health shares in Q2 2026, an estimated $27M.
- Guardant Health made up 1.43% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #14 holding.
- Emerald Mutual Fund Advisers Trust first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
- Emerald Mutual Fund Advisers Trust's Guardant Health position peaked at $53.5M in Q4 2025.
- 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.